[en] ("[en] OBJECTIVES: Sickle cell disease (SCD) encompasses health complications, primarily affecting the hematologic system and leading to high death rates in childhood. As a rule, the World Health Organisation (WHO) stepwise gold-standard about the strategies for prevention, diagnosis, and treatment of SCD must be multidimensional. This overview aimed to highlight current advances and challenges linked to strategic issues, diagnosis, the prevalence, and treatment of pediatric cases in Sub-Saharan Africa, particularly the Democratic Republic of the Congo.
METHODS: We searched data on Google Scholar, Medline, PubMed, Science Direct, Scopus, and ResearchGate.
RESULTS: The laboratory diagnosis of SCD has progressed from conventional electrophoresis to rapid point-of-care tests that allows early neonate screening. HemoTypeSCTM is an affordable test for neonatal screening in DRC. The pediatric SCD prevalence in Sub-Saharan Africa lay within 1-7.7% of homozygous(SS) and 15-40% of the heterozygous(AS) forms of SCD, depending on the method used and the ethnic population tested. Various supportive management protocols for comorbidities and complications exist, but they are not standardized in the Region.
CONCLUSION: Notwithstanding some progress accomplished, the disease is still challenging in Sub-Saharan Africa due to limited early diagnostic testing and a lack of specific medications. There is a need for harmonizing therapeutic protocols and conducting controlled valid clinical trials.","[en] ","")
Research center :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pediatrics
Author, co-author :
Kasai, Emmanuel Tebandite ; Department of Pediatrics, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Alworong'a Opara, Jean Pierre; Department of Pediatrics, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Ntokamunda Kadima, Justin; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Kalenga, Masendu ; Université de Liège - ULiège > Département des sciences cliniques
Batina Agasa, Salomon; Department of Internal Medicine, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Marini Djang'Eing'A, Roland ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique ; Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo
Boemer, François ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Language :
English
Title :
Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in Democratic Republic of the Congo.
ARES CCD - Académie de Recherche et d'Enseignement Supérieur. Coopération au Développement [BE]
Funding number :
Drepachild: Synergie-2020
Funding text :
The authors are grateful to the Academy of Research and Higher Education of the Belgian Development Cooperation for supporting the PRD-DREPAKIS project and the Synergie Save Drepachild project.
CDC. Hemoglobinopathies: current practices for screening, confirmation and follow-up. APHL. 2015. [Cited 2021 January 12]. Available from: https://www.cdc.gov/ncbddd/sicklecell/documents/nbs_hemoglobinopathy-testing_122015.pdf.
Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014; 42: D1063–9. DOI: 10.1093/nar/gkt911. Epub 2013 Oct 16.
Greene DN, Vaughn CP, Crews BO, et al. Advances in detection of hemoglobinopathies. Clin Chim Acta. 2015; 439: 50–57. DOI: 10.1016/j.cca.2014.10.006.
Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013 Jan 12; 381 (9861): 142–151. DOI: 10.1016/S0140-6736(12)61229-X.
Kazadi AL, Ngiyulu RM, Gini-Ehungu JL, et al. The clinical characteristics of Congolese children and adolescents suffering from sickle-cell anemia are marked by the high frequencies of epistaxis compared to western series. Pediatr Hematol Oncol. 2019; 36 (5): 267–276. DOI: 10.1080/08880018.2017.1365397.
Kondani DA, Gini-Ehungu JL, Bodi JM, et al. Prevalence of sickle cell disease in a pediatric population suffering from severe infections: a Congolese experience. Hemoglobin. 2014; 38 (4): 225–229. DOI: 10.3109/03630269.2014.917658.
Aloni MN, Kadima BT, Ekulu PM, et al. Acute crises and complications of sickle cell anemia among patients attending a pediatric tertiary unit in Kinshasa, Democratic Republic of Congo. Hematol Rep. 2017; 9: 6952. DOI: 10.4081/hr.2017.6952
Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: A prospective cohort study in Tanzania. PLoS One. 2011; 6: e14699. DOI: 10.1371/journal.pone.0014699.
Makani J, Ofori-Acquah SF, Nnodu O, et al. Sickle cell disease: new opportunities and challenges in Africa. Sci World J. 2013: 193252. DOI: 10.1155/2013/193252.
WHO. Sixtieth session of the WHO Regional Committee for Africa. 2019. [Cited 2021 January 12]. Available from: https://www.afro.who.int/about-us/governance/sessions/sixty-ninth-session-who-regional-committee-africa.
Kasai ET, Opara JPA, Agasa SB. Acceptabilité du Dépistage néonatal de la drépanocytose au cours de la pandémie au Covid-19 à kisangani, en République Démocratique du Congo. Pan African J Med. 2020; 37: 299. DOI: 10.11604/pamj.2020.37.299.26654.
OMS. Soixante-dixième session du Comité régional de l’OMS pour l’Afrique, 2020. [Cited 2021 september 9]. Available from: https://www.afro.who.int/fr/about-us/governance/sessions/soixante-dixieme-session-du-comite-regional-de-loms-pour-lafrique.
Hustace T, Fleisher JM, Sanchez-Varela AM, et al. Increased prevalence of false-positive hemoglobinopathy newborn screening in premature infants. Pediatr Blood Cancer. 2011; 57: 1039–1043. DOI: 10.1002/pbc.23173.
Franco RS, Yasin Z, Palascak MB, et al. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood. 2006; 108 (3): 1073–1076. DOI: 10.1182/blood-2005-09-008318.
Kasai ET, Boemer F, Djang’eing’a RM, et al. Systematic screening of neonatal sickle cell disease with HemoTypeSC Kit-test: case study and literature review. Open J Blood Diseases. 2020; 10: 12–21. DOI: 10.4236/2Fojbd.2020.101002.
Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31204 newborns. J Clin Pathol. 2009; 62: 35–38. DOI: 10.1136/jcp.2008.058958.
Ung R, Alapan Y, Hasan MN, et al. Point-of-care screening for sickle cell disease by a mobile micro-electrophoresis platform. Blood. 2015; 126 (23): 3379–3379.
Alapan Y, Fraiwan A, Kucukal E, et al. Emerging point-of-care technologies for sickle cell disease screening and monitoring. Expert Rev Med Devices. 2016; 13 (12): 1073–1093. DOI: 10.1080/17434440.2016.1254038.
Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010; 20 (1): 62–65. DOI: 10.1111/j.1365-3148.2009.00943.x.
Olatunya OS, Albuquerque DM, Fagbamigbe AF, et al. Diagnostic accuracy of HemotypeSC as a point-of-care testing device for sickle cell disease: findings from a southwestern state in Nigeria and implications for patient care in resource poor settings of sub-Saharan Africa. Global Pediatr Health. 2021; 8: 1–10. DOI: 10.1177/2333794X211016789.
Upadhye DS, Jain DL, Trivedi YL, et al. Newborn screening for haemoglobinopathies by high-performance liquid chromatography (HPLC): diagnostic utility of different approaches in resource-poor settings. Clin Chem Lab Med. 2014; 52: 1791–1796. DOI: 10.1515/cclm-2014-0452.
Clark BE, Thein SL. Molecular diagnosis of hemoglobin disorders. Clin Lab Haematol. 2004; 26 (3): 159–176. DOI: 10.1111/j.1365-2257.2004.00607.x.
Yue L, Lin M, Chen JT, et al. Rapid screening for sickle cell disease by polymerase chain reaction-high resolution melting analysis. Mol Med Rep. 2014; 9: 2479–2484. DOI: 10.3892/mmr.2014.2130.
Kadima BT, Gini-Ehungu JL, Ngiyulu RM, et al. High rate of sickle cell anemia in Sub-Saharan Africa underlines the need to screen all children with severe anaemia for the disease. Acta Paediatr. 2015; 104 (12): 1269–1273. DOI: 10.1111/apa.13040.
Mutesa L, Boemer F, Ngendahayo L, et al. Neonatal screening for sickle cell disease in Central Africa: a study of 1825 newborns with a new enzyme-linked immunosorbent assay test. J Med Screen. 2007; 14 (3): 113–116. DOI: 10.1258/096914107782066211.
Loufoua-Lemay ABM, Makoumbou P, Babela JRM. Dépistage néonatal de la drépanocytose au Congo Brazzaville. Ann L'Univ Marien Ngouabi. 2010; 11 (5): 21–25.
Délicat-Loembeta M, Elguero E, Arnathau C, et al. Prevalence of the sickle cell trait in Gabon: a nationwide study. Infect Genet Evol. 2014; 25: 52–56. DOI: 10.1016/j.meegid.2014.04.003.
Nankanja R, Kiyaga C, Geisberg M, et al. Implementation of a sickle cell disease screening initiative in Uganda with HemoTypeSCTM. Blood. 2018; 132 (1): LBA–LB3. DOI: 10.1182/blood-2018-120839.
Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir teaching hospital north Darfur state, Sudan. BMC Res Notes. 2019; 12: 659. DOI: 10.1186/s13104-019-4682-5
McAuley CF, Webb C, Makani J. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood. 2010; 116: 1663–1668. DOI: 10.1182/blood-2010-01-265249.
McGann PT, Ferris MG, Ramamurthy U, et al. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola. Am J Hematol. 2013; 88: 984–989. DOI: 10.1002/ajh.23578.
Cox SE, Doherty CP, Atkinson SH. Haptoglobin genotype, anemia, and malaria in Gambian children. Trop Med Int Health. 2008; 13: 76–82. DOI: 10.1002/ajh.23578.
Simpore J, Pignatelli S, Barlati S, et al. Modification in the frequency of Hb C and Hb S in Burkina Faso: influence of migratory fluxes and improvement of patient health care. Hemoglobin. 2002; 26: 113–120. DOI: 10.1081/hem-120005448.
Danquah I, Ziniel P, Eggelte TA, et al. Influence of haemoglobins S and C on predominantly asymptomatic Plasmodium infections in northern Ghana. Trans R Soc Trop Med Hyg. 2010; 104: 713–719. DOI: 10.1016/j.trstmh.2010.08.001.
Fleming AF, Storey J, Molineaux L, et al. Abnormal hemoglobins in the Sudan savanna of Nigeria. I. Prevalence of hemoglobins and relationships between sickle cell trait, malaria, and survival. Ann Trop Med, Parasitol. 1979; 73: 161–172. DOI: 10.1080/00034983.1979.11687243.
Diallo DA, Guindo A, Touré BA, et al. Targeted newborn screening for sickle-cell anemia: sickling test (Emmel test) boundaries in the prenatal assessment in West African area. Rev Epidemiol Sante Publ. 2018; 66 (3): 181–185. DOI: 10.1016/j.respe.2018.02.007.
Nkya S, Mtei L, Soka D, et al. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania. Int Health. 2019; 11: 589–595. DOI: 10.1093/inthealth/ihz028.
WHO. Sickle-cell disease: a strategy for the WHO African region. 2010. [Cited 2021 September 12]. Available from: https://apps.who.int/iris/handle/10665/1682.
Aloni MN, Nkee L. Challenge of managing sickle cell disease in a pediatric population living in Kinshasa, Democratic Republic of Congo: a sickle cell center experience. Hemoglobin. 2014; 38 (3): 196–200. DOI: 10.3109/03630269.2014.896810.
Kambale-Kombi P, Djang’eing’a RM, Opara JPA, et al. Students’ knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo. Hematology. 2020; 25: 91–94. DOI: 10.1080/16078454.2020.1727174.
Mukinayi BM, Kalenda DK, Mbelu S, et al. Awareness and attitudes of 50 Congolese families affected by sickle cell disease: a local survey. Pan Afr Med J. 2018; 29: 24. DOI: 10.11604/pamj.2018.29.24.12276
Kambale-Kombi P, Djang’eing’a RM, Opara JPA, et al. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematology. 2021; 26 (1): 199–205. DOI: 10.1080/16078454.2021.1880752.
Batina SA, Kambale PK, Sabiti MP, et al. Barriers to healthcare for sickle cell disease patients in the Democratic Republic Congo. Afr J Health Issues. 2017; 1: 2. DOI: 10.26875/ajhi112017ii.
Marks LJ, Munube D, Kasirye P, et al. Stroke prevalence in children with sickle cell disease in Sub-Saharan Africa: a systematic review and meta-analysis. Global Pediatr Health. 2018; 5: 1–9. DOI: 10.1177/2333794X18774970.
Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998; 339 (1): 5–11. DOI: 10.1056/NEJM199807023390102.
Kimaro FD, Jumanne S, Sindato EM, et al. Prevalence and factors associated with renal dysfunction among children with sickle cell disease attending the sickle cell disease clinic at a tertiary hospital in Northwestern Tanzania. PLoS One. 2019; 14 (6): e0218024. DOI: 10.1371/journal.pone.0218024.
Ahmad FA, Macias CG, Allen JY. The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. J Pediatr Hematol Oncol. 2011; 33 (6): 415–420. DOI: 10.1097/MPH.0b013e31821ed4ce.
Mabiala-Babela JR, Nika ER, Ikobo LCO, et al. Homozygous sickle cell children treated with Hydroxyurea in Brazzaville (Congo). Bull Soc Pathol Exotiq. 2019; 112 (4): 206–212. DOI: 10.3166/bspe-2019-0096.
Mukinayi BM, Cibeyibeyi GK, Tumba GD. Drépanocytose en République Démocratique du Congo: quels sont les obstacles à un traitement par hydroxyurée? PAM. 2021;38(41) disponible dans https://www.panafrican-med-journal.com/content/article/38/41/full visited on 8 th march 2021.
Tshilolo L, Tomlinson G, Williams TN, et al. Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa. N Engl J Med. 2019; 380: 121–131. DOI: 10.1056/NEJMoa1813598.
DeBaun MR, Jordan LC, King AA, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020; 4 (8): 1554–1588. DOI: 10.1182/bloodadvances.2019001142.
CDC. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60 (RR-7): 1–45.
Tshilolo L, Aissi LM, Ngasia B. Guide pratique de diagnostic précoce et de prise en de la drépanocytose en RDC. Centre de Formation et d’Appui sanitaire. RDC, 2009.
Arbuthnot P, Maepa MB, Pepper MS. The state of gene therapy research in Africa, its significance and implications for the future. gene therapy. Gene Ther. 2017; 24 (9): 581–589. DOI: 10.1038/gt.2017.57.
